References of "Kolh, Philippe"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailCorrigendum to "Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia" [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1-109>].
Conte, Michael S.; Bradbury, Andrew W.; Kolh, Philippe ULiege et al

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2020), 60(1), 158-159

Detailed reference viewed: 32 (1 ULiège)
Full Text
Peer Reviewed
See detailCentralization of Abdominal Aortic Aneurysm Repair - We Can No Longer Ignore the Benefits!
Wanhainen, Anders; Haulon, Stephan; Kolh, Philippe ULiege

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2020)

Detailed reference viewed: 43 (3 ULiège)
Full Text
Peer Reviewed
See detailReal Life Lessons in Peripheral Artery Disease - A Priority for Public Healthcare.
Ricco, Jean-Baptiste; Aboyans, Victor; Dick, Florian et al

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2020), 59(1), 5-6

Detailed reference viewed: 22 (1 ULiège)
Full Text
Peer Reviewed
See detailCorrigendum to “Real Life Lessons in Peripheral Artery Disease – A Priority for Public Healthcare” [Eur J Vasc Endovasc Surg 59 (1) (2020) 5–6](S107858841932636X)(10.1016/j.ejvs.2019.12.003)
Ricco, J.-B.; Aboyans, V.; Dick, F. et al

in European Journal of Vascular and Endovascular Surgery (2020)

The authors regret the following error: Throughout the text, Schwaneberg et al. should read Kreutzburg et al. in relation to reference 1, which is correct. The authors would like to apologise for any ... [more ▼]

The authors regret the following error: Throughout the text, Schwaneberg et al. should read Kreutzburg et al. in relation to reference 1, which is correct. The authors would like to apologise for any inconvenience caused. © 2020 [less ▲]

Detailed reference viewed: 20 (2 ULiège)
Full Text
Peer Reviewed
See detailEditor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections.
Chakfe, Nabil; Diener, Holger; Lejay, Anne et al

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2020), 59(3), 339-384

Detailed reference viewed: 24 (1 ULiège)
Full Text
Peer Reviewed
See detailCorrigendum to 'Management of Chronic Venous Disease: Clinical Practice Guidelines' [European Journal of Vascular & Endovascular Surgery 49/6 (2015) 678/737].
Wittens, C.; Davies, A. H.; Baekgaard, N. et al

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2020), 59(3), 495

Detailed reference viewed: 26 (2 ULiège)
Full Text
Peer Reviewed
See detailReply.
Conte, Michael S.; Bradbury, Andrew W.; Kolh, Philippe ULiege

in Journal of vascular surgery (2020), 71(1), 348-349

Detailed reference viewed: 19 (2 ULiège)
Full Text
Peer Reviewed
See detailLearning from Artificial Intelligence and Big Data in Health Care
Ricco, J.-B.; Guetarni, F.; Kolh, Philippe ULiege

in European Journal of Vascular and Endovascular Surgery (2020)

[No abstract available]

Detailed reference viewed: 60 (5 ULiège)
Full Text
Peer Reviewed
See detailCorrigendum to 'European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms' [European Journal of Vascular & Endovascular Surgery 57/1 (2019) 8-93].
Wanhainen, Anders; Verzini, Fabio; Van Herzeele, Isabelle et al

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2020), 59(3), 494

Detailed reference viewed: 22 (1 ULiège)
Full Text
Peer Reviewed
See detailCorrigendum to 'Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia' [European Journal of Vascular & Endovascular Surgery 58/1S (2019) 1-109].
Conte, Michael S.; Bradbury, Andrew W.; Kolh, Philippe ULiege et al

in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2020), 59(3), 492-493

Detailed reference viewed: 21 (1 ULiège)
Full Text
Peer Reviewed
See detailMetabolomics toward a personalized approach of vascular diseases
Leenders, Justine ULiege; vega de Ceninga, Melina; Chakfé, Nabil et al

in European Symposium on Vascular biomaterials 2019 (2019, October 17)

Personalized medicine could be described as the study of the most appropriate and tailored way to treat patients. This promising paradigm change in medicine care aims to place the patient at the center of ... [more ▼]

Personalized medicine could be described as the study of the most appropriate and tailored way to treat patients. This promising paradigm change in medicine care aims to place the patient at the center of the medical management and is expected to significantly improve the quality of life of the patient and to reduce the healthcare cost and the duration of hospital stay. It must combine modern and innovative tools to measure, integrate and model informative data that could help clinicians. Because it provides a unique insight into the relationships between physiological status, lifestyle, pathologies and patients, and because it correlates with a patient’s disease phenotype, metabolomics is particularly adapted to obtain relevant and helpful information for a personalized approach to treatment. Even if vascular care has evolved enormously in the last decades, with the development of innovative surgery and endovascular techniques, the improvement of the diagnostics tools and the optimization of new treatments, cardiovascular diseases (CVD) remain linked to a high prevalence and mortality. Then, application of an innovative personalized approach of CVD is mandatory and metabolomics represents clearly a well-adapted and powerful tool. This area of metabolomics is clearly emerging and, even if the number of studies involving “omics” sciences in CVD still remains limited in comparison with other pathologies such as cancer, cardiovascular metabolomics studies are notably in progression. [less ▲]

Detailed reference viewed: 39 (3 ULiège)
Full Text
Peer Reviewed
See detailMetabolomics as an Innovative Tool for a Personalised Approach to Vascular Disease
De Tullio, Pascal ULiege; Leenders, Justine ULiege; Vega de Ceniga, Melina et al

in European Journal of Vascular and Endovascular Surgery (2019), 57(3), 329

Detailed reference viewed: 28 (8 ULiège)
Full Text
Peer Reviewed
See detail2018 ESC/EACTS Guidelines on Myocardial Revascularization
Neumann, FJ; Sousa-Uva, M; Ahlsson, A et al

in European Heart Journal (2019), 40

Detailed reference viewed: 20 (1 ULiège)
Full Text
Peer Reviewed
See detailPercutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
Thuijs, Daniel J. F. M.; Kappetein, A. Pieter; Serruys, Patrick W. et al

in Lancet (London, England) (2019), 394(10206), 1325-1334

BACKGROUND: The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention (PCI) using first-generation paclitaxel ... [more ▼]

BACKGROUND: The Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention (PCI) using first-generation paclitaxel-eluting stents with coronary artery bypass grafting (CABG) in patients with de-novo three-vessel and left main coronary artery disease, and reported results up to 5 years. We now report 10-year all-cause death results. METHODS: The SYNTAX Extended Survival (SYNTAXES) study is an investigator-driven extension of follow-up of a multicentre, randomised controlled trial done in 85 hospitals across 18 North American and European countries. Patients with de-novo three-vessel and left main coronary artery disease were randomly assigned (1:1) to the PCI group or CABG group. Patients with a history of PCI or CABG, acute myocardial infarction, or an indication for concomitant cardiac surgery were excluded. The primary endpoint of the SYNTAXES study was 10-year all-cause death, which was assessed according to the intention-to-treat principle. Prespecified subgroup analyses were performed according to the presence or absence of left main coronary artery disease and diabetes, and according to coronary complexity defined by core laboratory SYNTAX score tertiles. This study is registered with ClinicalTrials.gov, NCT03417050. FINDINGS: From March, 2005, to April, 2007, 1800 patients were randomly assigned to the PCI (n=903) or CABG (n=897) group. Vital status information at 10 years was complete for 841 (93%) patients in the PCI group and 848 (95%) patients in the CABG group. At 10 years, 244 (27%) patients had died after PCI and 211 (24%) after CABG (hazard ratio 1.17 [95% CI 0.97-1.41], p=0.092). Among patients with three-vessel disease, 151 (28%) of 546 had died after PCI versus 113 (21%) of 549 after CABG (hazard ratio 1.41 [95% CI 1.10-1.80]), and among patients with left main coronary artery disease, 93 (26%) of 357 had died after PCI versus 98 (28%) of 348 after CABG (0.90 [0.68-1.20], pinteraction=0.019). There was no treatment-by-subgroup interaction with diabetes (pinteraction=0.66) and no linear trend across SYNTAX score tertiles (ptrend=0.30). INTERPRETATION: At 10 years, no significant difference existed in all-cause death between PCI using first-generation paclitaxel-eluting stents and CABG. However, CABG provided a significant survival benefit in patients with three-vessel disease, but not in patients with left main coronary artery disease. FUNDING: German Foundation of Heart Research (SYNTAXES study, 5-10-year follow-up) and Boston Scientific Corporation (SYNTAX study, 0-5-year follow-up). [less ▲]

Detailed reference viewed: 33 (4 ULiège)
Full Text
Peer Reviewed
See detail2018 ESC/EACTS Guidelines on myocardial revascularization.
Sousa-Uva, Miguel; Neumann, Franz-Josef; Ahlsson, Anders et al

in European Journal of Cardio-Thoracic Surgery (2019), 55(1), 4-90

Detailed reference viewed: 24 (4 ULiège)
Full Text
Peer Reviewed
See detailTreatment of Thoracic and Thoraco-abdominal Aortic Pathology in the Endovascular Era.
Mani, Kevin; Kolh, Philippe ULiege; Lepidi, Sandro

in European Journal of Vascular and Endovascular Surgery (2019), 57

Detailed reference viewed: 19 (1 ULiège)
Full Text
Peer Reviewed
See detailGlobal vascular guidelines on the management of chronic limb-threatening ischemia
Conte, M. S.; Bradbury, A. W.; Kolh, Philippe ULiege et al

in Journal of Vascular Surgery (2019), 69(6), 3-12540

Chronic limb-threatening ischemia (CLTI)is associated with mortality, amputation, and impaired quality of life. These Global Vascular Guidelines (GVG)are focused on definition, evaluation, and management ... [more ▼]

Chronic limb-threatening ischemia (CLTI)is associated with mortality, amputation, and impaired quality of life. These Global Vascular Guidelines (GVG)are focused on definition, evaluation, and management of CLTI with the goals of improving evidence-based care and highlighting critical research needs. The term CLTI is preferred over critical limb ischemia, as the latter implies threshold values of impaired perfusion rather than a continuum. CLTI is a clinical syndrome defined by the presence of peripheral artery disease (PAD)in combination with rest pain, gangrene, or a lower limb ulceration >2 weeks duration. Venous, traumatic, embolic, and nonatherosclerotic etiologies are excluded. All patients with suspected CLTI should be referred urgently to a vascular specialist. Accurately staging the severity of limb threat is fundamental, and the Society for Vascular Surgery Threatened Limb Classification system, based on grading of Wounds, Ischemia, and foot Infection (WIfI)is endorsed. Objective hemodynamic testing, including toe pressures as the preferred measure, is required to assess CLTI. Evidence-based revascularization (EBR)hinges on three independent axes: Patient risk, Limb severity, and ANatomic complexity (PLAN). Average-risk and high-risk patients are defined by estimated procedural and 2-year all-cause mortality. The GVG proposes a new Global Anatomic Staging System (GLASS), which involves defining a preferred target artery path (TAP)and then estimating limb-based patency (LBP), resulting in three stages of complexity for intervention. The optimal revascularization strategy is also influenced by the availability of autogenous vein for open bypass surgery. Recommendations for EBR are based on best available data, pending level 1 evidence from ongoing trials. Vein bypass may be preferred for average-risk patients with advanced limb threat and high complexity disease, while those with less complex anatomy, intermediate severity limb threat, or high patient risk may be favored for endovascular intervention. All patients with CLTI should be afforded best medical therapy including the use of antithrombotic, lipid-lowering, antihypertensive, and glycemic control agents, as well as counseling on smoking cessation, diet, exercise, and preventive foot care. Following EBR, long-term limb surveillance is advised. The effectiveness of nonrevascularization therapies (eg, spinal stimulation, pneumatic compression, prostanoids, and hyperbaric oxygen)has not been established. Regenerative medicine approaches (eg, cell, gene therapies)for CLTI should be restricted to rigorously conducted randomizsed clinical trials. The GVG promotes standardization of study designs and end points for clinical trials in CLTI. The importance of multidisciplinary teams and centers of excellence for amputation prevention is stressed as a key health system initiative. © 2019 Society for Vascular Surgery and European Society for Vascular Surgery [less ▲]

Detailed reference viewed: 714 (9 ULiège)
Full Text
Peer Reviewed
See detailAnalyse the evidence, generate new evidence and apply the evidence: cardiac surgery is not only about cutting and sewing.
Gaudino, Mario; Schwann, Thomas; Puskas, John et al

in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2019)

Detailed reference viewed: 26 (3 ULiège)
Full Text
Peer Reviewed
See detailRoutine preoperative aortic computed tomography angiography is associated with reduced risk of stroke in coronary artery bypass grafting: a propensity-matched analysis.
Sandner, Sigrid E.; Nolz, Richard; Loewe, Christian et al

in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2019)

OBJECTIVES: The aim of this study was to determine stroke rates in patients who did or did not undergo routine computed tomography angiography (CTA) aortic imaging before isolated coronary artery bypass ... [more ▼]

OBJECTIVES: The aim of this study was to determine stroke rates in patients who did or did not undergo routine computed tomography angiography (CTA) aortic imaging before isolated coronary artery bypass grafting (CABG). METHODS: We conducted a retrospective analysis of a prospectively maintained single-centre registry. Between 2009 and 2016, a total of 2320 consecutive patients who underwent isolated CABG at our institution were identified. Propensity score matching was used to create a paired cohort of patients with similar baseline characteristics who did (CTA cohort) or did not (non-CTA cohort) undergo preoperative aortic CTA. The primary end point of the analysis was in-hospital stroke. RESULTS: In 435 propensity score-matched pairs, stroke occurred in 4 patients (0.92%) in the CTA cohort and in 14 patients (3.22%) in the non-CTA cohort (P = 0.017). Routine preoperative aortic CTA was associated with a significantly reduced risk of in-hospital stroke [relative risk 0.29, 95% confidence interval (CI) 0.09-0.86; P = 0.026; absolute risk reduction 2.3%, 95% CI 0.4-4.2; P = 0.017; number needed to treat = 44, 95% CI 24-242]. CONCLUSIONS: A preoperative screening for atheromatous aortic disease using CTA is associated with reduced risk of stroke after CABG. The routine use of preoperative aortic CTA could be applied so that surgical manipulation of the ascending aorta can be selectively reduced or avoided in patients with atheromatous aortic disease. [less ▲]

Detailed reference viewed: 22 (0 ULiège)